Published in Minerva Urol Nefrol on September 01, 2011
European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol (2004) 2.65
The ICS-'BPH' Study: the psychometric validity and reliability of the ICSmale questionnaire. Br J Urol (1996) 1.89
Comparison of orthotopic sigmoid and ileal neobladders: continence and urodynamic parameters. Eur Urol (2004) 1.52
Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer. Ann Oncol (2012) 1.44
The bell-shaped nitinol prostatic stent in the treatment of lower urinary tract symptoms: experience in 108 patients. Eur Urol (2006) 1.44
Urinary tract infections following laser prostatectomy: is there a need for antibiotic prophylaxis? Br J Urol (1996) 1.38
Tubeless percutaneous nephrolithotomy--the new standard of care? J Urol (2010) 1.31
Positive margins in laparoscopic partial nephrectomy in 855 cases: a multi-institutional survey from the United States and Europe. J Urol (2007) 1.31
Influence of cataract on optical coherence tomography image quality and retinal thickness. Br J Ophthalmol (2006) 1.28
Present practice and treatment strategies in endourological stone management: results of a survey of the European Society of Uro-technology (ESUT). Eur Urol (2005) 1.24
Prognostic factors and percutaneous nephrolithotomy morbidity: a multivariate analysis of a contemporary series using the Clavien classification. J Urol (2008) 1.21
[EAU guidelines on testicular cancer: 2011 update. European Association of Urology]. Actas Urol Esp (2011) 1.19
Treatment of mid- and lower ureteric calculi: extracorporeal shock-wave lithotripsy vs laser ureteroscopy. A comparison of costs, morbidity and effectiveness. Br J Urol (1998) 1.11
Determination of the scattering anisotropy with optical coherence tomography. Opt Express (2011) 1.06
Quantitative comparison of the OCT imaging depth at 1300 nm and 1600 nm. Biomed Opt Express (2010) 1.05
Prostate-specific antigen as an estimator of prostate volume in the management of patients with symptomatic benign prostatic hyperplasia. Eur Urol (2003) 1.03
Testicular seminoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol (2009) 1.00
Optical biopsy of epithelial cancers by optical coherence tomography (OCT). Lasers Med Sci (2013) 0.94
Laparoscopic extraperitoneal adenomectomy (Millin): pilot study on feasibility. Eur Urol (2004) 0.93
Multiple and dependent scattering effects in Doppler optical coherence tomography. Opt Express (2010) 0.91
First experiences of photoacoustic imaging for detection of melanoma metastases in resected human lymph nodes. Lasers Surg Med (2012) 0.89
Transrectal ultrasound of the prostate: innovations and future applications. J Urol (1998) 0.89
Quantitative optical coherence tomography of arterial wall components. Lasers Med Sci (2005) 0.87
Reproducibility of prostate volume measurements from transrectal ultrasonography by an automated and a manual technique. Br J Urol (1996) 0.87
The tolerability of urodynamic studies and flexible cysto-urethroscopy used in the assessment of men with lower urinary tract symptoms. BJU Int (1999) 0.86
The role for active monitoring in urinary stones: a systematic review. J Endourol (2010) 0.84
Dependent and multiple scattering in transmission and backscattering optical coherence tomography. Opt Express (2013) 0.84
Post-void residual urine volume is not a good predictor of the need for invasive therapy among patients with benign prostatic hyperplasia. J Urol (2006) 0.83
Optical coherence tomography of the Ex-PRESS miniature glaucoma implant. Lasers Med Sci (2005) 0.82
[Cryotherapy for renal tumors: current status and contemporary developments]. Actas Urol Esp (2010) 0.81
Transurethral resection of the prostate vs high-energy thermotherapy of the prostate in patients with benign prostatic hyperplasia: long-term results. Br J Urol (1998) 0.80
Functional optical coherence tomography of pigmented lesions. J Eur Acad Dermatol Venereol (2014) 0.80
Testicular non-seminoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol (2009) 0.79
Arterial remodeling after balloon angioplasty of the coronary artery: an intravascular ultrasound study. PICTURE Investigators. PostTreatment IntraCoronary Transluminal Ultrasound Result Evaluation. Am Heart J (1997) 0.77
Macular pigment optical density measurements: evaluation of a device using heterochromatic flicker photometry. Eye (Lond) (2010) 0.77
The role of imaging in the active surveillance of small renal masses. Curr Urol Rep (2014) 0.76
Cryotherapy for renal-cell cancer: diagnosis, treatment, and contrast-enhanced ultrasonography for follow-up. J Endourol (2006) 0.76
Expression of periglandular tenascin-C and basement membrane laminin in normal prostate, benign prostatic hyperplasia and prostate carcinoma. Br J Urol (1998) 0.76
Evaluation of renal masses with contrast-enhanced ultrasound. Curr Urol Rep (2013) 0.76
[Diagnosis of upper urinary tract tumors. A pending challenge]. Arch Esp Urol (2014) 0.75
[Intraprostatic prostheses]. J Urol (Paris) (1993) 0.75
[Acute colonic pseudo-obstruction (Ogilvie syndrome) after nephrectomy for renal carcinoma: persistence after decompressive colonoscopy and spontaneous remission]. Actas Urol Esp (1993) 0.75
Colour oscillations in arterioarterial anastomoses reflect natural differences in donor and recipient oxygenation and hematocrit. Placenta (2006) 0.75
Long-term results after external beam radiation therapy for T1-T2 localized prostate cancer. Curr Urol Rep (2003) 0.75
[Gastrocystoplasty for renal insufficiency in adults]. Actas Urol Esp (1993) 0.75
Laparoscopic cryotherapy for small renal masses: Current State. Arch Esp Urol (2013) 0.75
Efficacy and safety of the new high-energy 30-minute transurethral microwave thermotherapy: results of 1-year follow-up in a multicenter study. Tech Urol (2000) 0.75
[Percutaneous suprapubic bladder lithotripsy]. Ann Urol (Paris) (1998) 0.75
[Treatment of superficial bladder tumors]. Pathol Biol (Paris) (1990) 0.75
Transurethral hot water balloon thermoablation. Curr Urol Rep (2001) 0.75
Carcinoma in situ as a prognostic factor for G3pT1 bladder tumours. Br J Urol (1991) 0.75
Urinary leakage after laparoscopic radical prostatectomy: a systematic review. J Endourol (2007) 0.75
Focal therapy for prostate cancer: current status and future perspectives. Minerva Urol Nefrol (2015) 0.75
Laparoscopic radical prostatectomy: a European virus. Minim Invasive Ther Allied Technol (2005) 0.75